ArticlePediatric surgery international2025
Thoracoscopic hiatoplasty in congenital diaphragmatic hernia is safe and less invasive: a prospective propensity-matched short-term study.
Article in Pediatric surgery international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCongenital diaphragmatic hernia (CDH) is a condition linked to neonatal morbidity, mortality, and gastroesophageal reflux. Traditional hiatoplasty via laparotomy or laparoscopy is complicated by abdominal adhesions from previous CDH repair. A thoracoscopic technique, avoiding abdominal preparation, was introduced to address these issues. This study evaluates its safety and efficacy in children with CDH.
methodsA prospective, propensity-matched study was conducted on pediatric patients undergoing thoracoscopic hiatoplasty (TH) or hiatoplasty via laparotomy for CDH at University Hospital Mannheim (2013-2024). Outcomes included operative time, ICU LOS and overall hospital stay (LOS), complication rates, and recovery, assessed via parent-reported questionnaires.
results57 children underwent hiatoplasty via laparotomy, while 12 had TH. Propensity matching yielded 27 patients (laparotomy n = 19, TH n = 8). TH showed shorter operative time (71.5 vs 190.5 min; p = 0.0018), reduced ICU LOS (0.1 ± 0.3 vs 1.6 ± 4.0 days; p = 0.0002), and shorter overall LOS (2.4 ± 1.1 vs 13.2 ± 6.1 days; p < 0.0001). Complications were fewer (p = 0.0022), and dietary progression improved (p = 0.0181), with a trend toward earlier sports resumption (p = 0.0545). Follow-up duration was markedly shorter in the TH group (median 109 days [IQR 70-151] vs. 1465 days [IQR 924-2390], p = 0.0041).
conclusionTH is a safe, effective antireflux therapy for CDH, offering better recovery and fewer complications. Interpretation is limited by the shorter follow-up in the thoracoscopic group. Long-term randomized trials are needed to confirm these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.